Pharmaceutical goods; placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses

300693 (Harmonized System 2022 for 6-digit)

About

Overview This page contains the latest trade data of Clinical trial kits. In 2022, Clinical trial kits were the world's 2143rd most traded product, with a total trade of $1.17B.

Clinical trial kits are a part of Special Pharmaceuticals.

Exports In 2022 the top exporters of Clinical trial kits  were United States ($258M), Germany ($120M), France ($86.8M), Malaysia ($84M), and Belgium ($67M).

Imports In 2022 the top importers of Clinical trial kits were United States ($233M), Malaysia ($161M), Germany ($72.7M), Netherlands ($58.5M), and United Kingdom ($54.3M).

Ranking Clinical trial kits ranks 2671st in the Product Complexity Index (PCI).

Latest Data

View
Flow
Y-AXIS SCALE

The following visualization shows the latest trends on Clinical trial kits. Countries are shown based on data availability.

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

Explore Latest Trends

* Trade values are converted to USD using each month's exchange rate. For December 2023 data, the exchange rate from December 30, 2023 is used.

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Exporters and Importers

Top Origin (2022)United States$258M
Top Destination (2022)United States$233M

In 2022 Clinical trial kits were the world's 2143rd most traded product (out of 5,606).

In 2022, the top exporters of Clinical trial kits were United States ($258M), Germany ($120M), France ($86.8M), Malaysia ($84M), and Belgium ($67M).

In 2022, the top importers of Clinical trial kits were United States ($233M), Malaysia ($161M), Germany ($72.7M), Netherlands ($58.5M), and United Kingdom ($54.3M).

Explore Visualizations

Exporters of Clinical trial kits (2022)
[Click to Select a Country]

Importers of Clinical trial kits (2022)
[Click to Select a Country]

Market Dynamics

Color
Top Origin Growth (false -  2022)United States$258M
Top Destination Growth (false -  2022)United States$233M

Between false and 2022, the exports of Clinical trial kits grew the fastest in United States ($258M), Germany ($120M), France ($86.8M), Malaysia ($84M), and Belgium ($67M).

Between false and 2022, the fastest growing importers of Clinical trial kits were United States ($233M), Malaysia ($161M), Germany ($72.7M), Netherlands ($58.5M), and United Kingdom ($54.3M).

Explore Visualizations

Exporters of Clinical trial kits (NaN - 2022)

Importers of Clinical trial kits (NaN - 2022)

Net Trade

TOP NET EXPORTER (2022)France$60.4M
TOP NET IMPORTER (2022)Malaysia$77.4M

This map shows which countries export or import more of Clinical trial kits. Each country is colored based on the difference in exports and imports of Clinical trial kits during 2022.

In 2022, the countries that had a largest trade value in exports than in imports of Clinical trial kits were France ($60.4M), Germany ($47.2M), Belgium ($28.9M), Spain ($24.2M), and United States ($24.2M).

In 2022, the countries that had a largest trade value in imports than in exports of Clinical trial kits were Malaysia ($77.4M), Netherlands ($42.5M), Australia ($28.4M), Japan ($19.7M), and Israel ($15.6M).

Net Trade (2022)

Product Complexity

Diversification Frontier

Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.

Relatedness vs Country Complexity (2022)

Have questions, comments, or concerns?
Send us an e-mail: [email protected]
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with